09/15/2018
Aris Karatasakis, MD; Michael R. Wyman, MD; Subhash Banerjee, MD, FSCAI; Barbara Anna Danek, MD; Anthony H. Doing, MD; Bavana V. Rangan, BDS, MPH, MD; Catalin Toma, MD; Barry F. Uretsky, MD; James W. Choi, MD; Ehtisham Mahmud, MD; Ioannis Tsiafoutis, MD; Peter Tajti, MD; Mitul P. Patel, MD; Michalis Koutouzis, MD, PhD; Oleg Krestyaninov, MD; Santiago Garcia, MD; Iosif Xenogiannis, MD; Dmitrii Khelimskii, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; M. Nicholas Burke, MD; Elizabeth Holper, MD; Khaldoon Alaswad, MD; Dimitrios Karmpaliotis, MD, PhD; Imre Ungi, MD, PhD; Farouc A. Jaffer, MD, PhD; Robert W. Yeh, MD, MBA, MSc
We evaluated the prevalence of CKD and its impact on CTO-PCI outcomes in 1979 patients who underwent 2040 procedures between 2012 and 2017 at 18 centers.
We evaluated the prevalence of CKD and its impact on CTO-PCI outcomes in 1979 patients who underwent 2040 procedures between 2012 and 2017 at 18 centers.
We evaluated the prevalence of...